AHA, AHIP OpEd: When Your Medication Costs More Than Your Mortgage
“Prescription drug prices are out of control,” wrote AHA President and CEO Rick Pollack and America’s Health Insurance Plans President and CEO Marilyn Tavenner in a Dec. 31 OpEd in The Hill. “The average annual cost for one specialty medication to treat a chronic condition is now more than what most families earn in a year. Big Pharma could solve the problem by committing to more rational and sustainable pricing models. Instead, for the last year, Big Pharma has chosen to point the finger at everyone else, and their decision to engage in a blame game is a tacit admission that drug prices are, in fact, too high.” To read the full column, click here.
Related News Articles
Headline
The AHA again is asking the Health Resources and Services Administration to take action after Eli Lilly warned hospitals that they could lose access to…
Headline
The administration Apri 23 reached a most-favored-nation drug pricing agreement with Regeneron, the maker of the popular cholesterol medicine Praluent. This is…
Headline
The AHA April 23 released a blog responding to a report issued April 22 by Paragon Health Institute. The blog highlights how the report relies on a long list…
Blog
In think‑tank reports, like the one released this week by Paragon Health Institute, hospitals are often reduced to abstractions — payment rates, charts,…
Headline
The Centers for Medicare & Medicaid Services announced in a memo April 21that it is delaying implementation of the Medicare Part D portion of the Better…
Headline
Rep. Blake Moore, R-Utah, vice chair, House Republican Conference and member of the House Ways and Means Committee and its Subcommittee on Health, joined Bill…